Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Creative Bioarray

Located at Long Island, New York, Creative Bioarray was founded as biomedical company focused on providing comprehensive biotechnology and pharmaceutical array services and products for high-throughput analysis. Creative Bioarray uniquely pioneers the development of high quality tissue, antibody, protein and cell array technology to efficiently analyze the concurrent expression and function of proteins involved in inflammation, angiogenesis, apoptosis, cell growth, and signal transduction from a single biological sample.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Dice Medical Communications Logo

Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.

View Profile

Advertising, Branding, Conference/meetings/events, Creative and design, Digital communications, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Sales, Training

- PMLiVE

Innovative Trials

Innovative Trials is a leading global clinical trial patient recruitment company. With over 10 years’ of experience, Innovative Trials deploys ‘boots-on-the-ground’ recruitment experts in over 70 countries, addressing individual sites’…

View Profile

Sales

Company Details

Creative Bioarray
45-16 Ramsey Road Shirley, New York, NY 11967, United States
+1 631 624 4882
Contact Creative Bioarray
Website

 Latest Content from PMHub 

5 key digital CX challenges in pharma, and how to start solving them

Press Releases | December 2, 2025 | Graphite Digital

Creating great digital experiences in pharma isn’t easy, but progress doesn’t always need to come from big projects or budgets. Here are 5 common challenges that leading digital teams are...

Medscape at ASH 2025: Landmark Value Through the Medscape AI Debut and Five Educational Symposia

Press Releases | December 1, 2025 | Medscape Education

For decades, Medscape has been the brand physicians trust. Now, Medscape is forging a new path into the future at ASH 2025 with the launch of Medscape AI — the...

Behind the scenes: why we created ‘The participation equation’

White Papers and Resources | November 28, 2025 | Cuttsy + Cuttsy

Go behind the scenes of The participation equation – our call to put people, not just data, at the heart of clinical research.

Reframing the Obesity Conversation: Key Takeaways from ObesityWeek® 2025

White Papers and Resources | November 28, 2025 | Inizio

As the understanding of obesity continues to evolve, so too does the science, patient experience, and cross-sector collaboration driving innovation. At ObesityWeek® 2025 in Atlanta, experts from across Inizio reflected...

Cuttsy+Cuttsy launches R:SQD – a new way to predict and improve trial success

Press Releases | November 27, 2025 | Cuttsy + Cuttsy

Cuttsy+Cuttsy has launched R:SQD, an innovative recruitment and retention success scoring tool that helps clinical trial sponsors predict, measure, and improve participant engagement and trial outcomes.

Does real-world use of AI in systematic literature reviews result in time and cost savings?

White Papers and Resources | November 27, 2025 | Amiculum

By Manca Povsic and Emma Griffiths

How DataGateway unified oncology data for real-world insights & market intelligence

White Papers and Resources | November 26, 2025 | Inizio

Discover how our DataGateway platform unifies fragmented real-world oncology data into a single, validated dataset that delivers deeper insights and faster decision-making.

Inizio launches InConcert™ to transform pre-launch planning through connected intelligence.

Press Releases | November 26, 2025 | Inizio

Inizio today announced the launch of InConcert™, a new AI-powered data solution designed to accelerate smarter, evidence-led decisions during the critical pre-launch phase of the product lifecycle.

ESMO 2025 highlights: How storytelling, design & emotion are transforming scientific engagement

White Papers and Resources | November 26, 2025 | Inizio

Discover key insights from ESMO 2025 on how design, emotion, and sustainability are reshaping medical congress experiences. Featuring expert takes from Inizio leaders.

Is Joint Clinical Assessment (JCA) appropriate for assessing the broader value of vaccines?

White Papers and Resources | November 21, 2025 | Amiculum

By Emily Morton-West